PROM1 and osteosarcoma: In another study in a Saos-2 osteosarcoma xenograft mouse model, SLM-loaded PEGylated PLGA NPs, surface modified with CD133 aptamer, eliminated CD133-positive osteosarcoma CSCs in vitro and in vivo [38].